Stuart Osborne
- Gastroenterology top 2%
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 12
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 7
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 5
- Hepatology top 5%
-
- Lymphoma Diagnosis and Treatment 8
-
- Lung Cancer Treatments and Mutations 8
-
- Cancer Genomics and Diagnostics 5
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- David CunninghamMark SaundersIstván LángDaniel WaterkampJanja OcvirkDerek J. JonkerDong Bok ShinVito Lorusso
- Cited by
- GastroenterologyOncologyGenetics
- Journals
- Annals of Oncology (11 papers)Journal of Clinical Oncology (6 papers)The Journal of Clinical Pharmacology (4 papers)
- Partner nations
- SwitzerlandFranceGermany
In The Last Decade
Stuart Osborne
56 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Gastroenterology 310
- Oncology 919
- Genetics 220
- Hepatology 140
- Pathology and Forensic Medicine 305
Countries citing papers authored by Stuart Osborne
This map shows the geographic impact of Stuart Osborne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Osborne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Osborne more than expected).
Fields of papers citing papers by Stuart Osborne
This network shows the impact of papers produced by Stuart Osborne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Osborne. The network helps show where Stuart Osborne may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stuart Osborne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 19 | |
| 2 | 2021 | 28 | |
| 3 | 2020 | 13 | |
| 4 | 2020 | 2 | |
| 5 | 2020 | 9 | |
| 6 | 2018 | 50 | |
| 7 | 2018 | 112 | |
| 8 | 2018 | 10 | |
| 9 | 2016 | 100 | |
| 10 | Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study | 2015 | 10 |
| 11 | 2014 | 13 | |
| 12 | 2013 | 24 | |
| 13 | 2013 | 1 | |
| 14 | Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trialbreakdown → | 2013 | 438 |
| 15 | 2003 | 11 | |
| 16 | 2003 | 6 | |
| 17 | 2001 | 22 | |
| 18 | 2001 | 175 | |
| 19 | 2000 | 9 | |
| 20 | 1999 | 27 |
About Stuart Osborne
Stuart Osborne is a scholar working on Oncology, Dermatology, Genetics, Gastroenterology and Cancer Research, having authored 56 papers that have together received 1.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Cancer Treatment and Pharmacology (9 papers), Lung Cancer Treatments and Mutations (8 papers), Lymphoma Diagnosis and Treatment (8 papers), HER2/EGFR in Cancer Research (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Gastroenterology (310 citations), Oncology (919 citations), Genetics (220 citations), Hepatology (140 citations) and Pathology and Forensic Medicine (305 citations). Stuart Osborne has collaborated with scholars based in Switzerland, France and Germany. Frequent co-authors include David Cunningham, Mark Saunders, István Láng, Daniel Waterkamp, Janja Ocvirk, Derek J. Jonker, Dong Bok Shin, Vito Lorusso, Eugenio Marcuello and Silke Appel‐Dingemanse. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, The Journal of Clinical Pharmacology, Gastroenterology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.